Skip to main content
Premium Trial:

Request an Annual Quote

Vanderbilt Researchers to Use Waters' Synapt in Oncology Studies

NEW YORK (GenomeWeb News) – Waters announced today that researchers at Vanderbilt University will use the firm’s Synapt HDMS system to enhance their tissue imaging capabilities in oncology studies being conducted at the school’s Mass Spectrometry Research Center.
Researchers at the center are using mass spec technologies to identify and visualize protein expression changes in cells through various stages of cancer.
“Ultimately, we hope that enhanced tissue imaging techniques will provide data sets to be mined for diagnostic and prognostic information related to the various stages of cancer,” Richard Caprioli, director of Vanderbilt’s MSRC, said in a statement.
Waters introduced the Synapt HDMS at the annual American Society of Mass Spectrometry meeting in June 2006. The platform incorporates high efficiency ion mobility separation in a dual ionization mass spectrometer. Over the past few quarters company officials have cited the instrument as a key revenue growth driver.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.